Year |
Citation |
Score |
2020 |
Bilousova T, Simmons BJ, Knapp RR, Elias CJ, Campagna J, Melnik M, Chandra S, Focht S, Zhu C, Vadivel K, Jagodzinska B, Cohn W, Spilman P, Gylys KH, Garg NK, et al. Dual Neutral Sphingomyelinase-2/Acetylcholinesterase Inhibitors for the treatment of Alzheimer's disease. Acs Chemical Biology. PMID 32352753 DOI: 10.1021/Acschembio.0C00311 |
0.329 |
|
2019 |
Bilousova T, Melnik M, Miyoshi E, Gonzalez BL, Poon WW, Vinters HV, Miller CA, Corrada MM, Kawas C, Hatami A, Albay R, Glabe C, Gylys KH. Apolipoprotein E/Aβ Complex Accumulates in AD Cortical Synapses via apoE Receptors and Is Enhanced by APOE4. The American Journal of Pathology. PMID 31108099 DOI: 10.1016/J.Ajpath.2019.04.010 |
0.352 |
|
2019 |
Campagna JJ, Spilman P, Elias CJ, Zhu C, Bilousova T, Jun M, Bai D, Pham J, Kim YS, Bredesen DE, Jung M, John V. P2-176: IDENTIFICATION OF AN EXPERIMENTAL DRUG THAT ENHANCES BRAIN SIRTUIN 1 LEVELS AND IMPROVES COGNITION AS A POTENTIAL NEW THERAPEUTIC FOR AD Alzheimer's & Dementia. 15: P644-P644. DOI: 10.1016/J.Jalz.2019.06.2583 |
0.32 |
|
2018 |
Campagna J, Spilman P, Jagodzinska B, Bai D, Hatami A, Zhu C, Bilousova T, Jun M, Elias CJ, Pham J, Cole G, LaDu MJ, Jung ME, Bredesen DE, John V. A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer's disease mouse model. Scientific Reports. 8: 17574. PMID 30514854 DOI: 10.1038/S41598-018-35687-8 |
0.366 |
|
2018 |
Bilousova T, Elias C, Miyoshi E, Alam MP, Zhu C, Campagna J, Vadivel K, Jagodzinska B, Gylys K, John V. Suppression of tau propagation using an inhibitor that targets the DK-switch of nSMase2. Biochemical and Biophysical Research Communications. PMID 29604274 DOI: 10.1016/J.Bbrc.2018.03.209 |
0.336 |
|
2018 |
Ma QL, Teng E, Zuo X, Jones M, Teter B, Zhao EY, Zhu C, Bilousova T, Gylys KH, Apostolova LG, LaDu MJ, Hossain MA, Frautschy SA, Cole GM. Neuronal pentraxin 1: A synaptic-derived plasma biomarker in Alzheimer's disease. Neurobiology of Disease. PMID 29501530 DOI: 10.1016/J.Nbd.2018.02.014 |
0.37 |
|
2017 |
Gylys KH, Bilousova T. Flow Cytometry Analysis and Quantitative Characterization of Tau in Synaptosomes from Alzheimer's Disease Brains. Methods in Molecular Biology (Clifton, N.J.). 1523: 273-284. PMID 27975256 DOI: 10.1007/978-1-4939-6598-4_16 |
0.308 |
|
2016 |
Prieto GA, Trieu BH, Dang CT, Bilousova T, Gylys KH, Berchtold NC, Lynch G, Cotman CW. Pharmacological rescue of long-term potentiation in Alzheimer diseased synapses. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 27986924 DOI: 10.1523/Jneurosci.2774-16.2016 |
0.361 |
|
2016 |
Heinzelman P, Bilousova T, Campagna J, John V. Nanoscale Extracellular Vesicle Analysis in Alzheimer's Disease Diagnosis and Therapy. International Journal of Alzheimer's Disease. 2016: 8053139. PMID 27213078 DOI: 10.1155/2016/8053139 |
0.349 |
|
2016 |
Bilousova T, Miller CA, Poon WW, Vinters HV, Corrada M, Kawas C, Hayden EY, Teplow DB, Glabe C, Albay R, Cole GM, Teng E, Gylys KH. Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases. The American Journal of Pathology. 186: 185-98. PMID 26718979 DOI: 10.1016/J.Ajpath.2015.09.018 |
0.365 |
|
2015 |
Teng E, Taylor K, Bilousova T, Weiland D, Pham T, Zuo X, Yang F, Chen PP, Glabe CG, Takacs A, Hoffman DR, Frautschy SA, Cole GM. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization. Neurobiology of Disease. PMID 26369878 DOI: 10.1016/J.Nbd.2015.09.002 |
0.317 |
|
2015 |
Wang DB, Kinoshita Y, Kinoshita C, Uo T, Sopher BL, Cudaback E, Keene CD, Bilousova T, Gylys K, Case A, Jayadev S, Wang HG, Garden GA, Morrison RS. Loss of endophilin-B1 exacerbates Alzheimer's disease pathology. Brain : a Journal of Neurology. 138: 2005-19. PMID 25981964 DOI: 10.1093/Brain/Awv128 |
0.37 |
|
2015 |
Bilousova T, Taylor K, Emirzian A, Gylys R, Frautschy SA, Cole GM, Teng E. Parallel age-associated changes in brain and plasma neuronal pentraxin receptor levels in a transgenic APP/PS1 rat model of Alzheimer's disease. Neurobiology of Disease. 74: 32-40. PMID 25449907 DOI: 10.1016/J.Nbd.2014.11.006 |
0.349 |
|
2015 |
Sokolow S, Henkins KM, Bilousova T, Gonzalez B, Vinters HV, Miller CA, Cornwell L, Poon WW, Gylys KH. Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's disease. Journal of Neurochemistry. 133: 368-79. PMID 25393609 DOI: 10.1111/Jnc.12991 |
0.362 |
|
2015 |
Gylys KH, Bilousova T, Teng E, Vinters HV, Miller CA, Poon WW, Apostolova LG, Frautschy SA, John V, Bredesen DE, Cole GM. O2-06-03: Release of c-terminal truncated and intact tau from Alzheimer's disease cortical synapses Alzheimer's & Dementia. 11: P186-P187. DOI: 10.1016/J.Jalz.2015.07.161 |
0.317 |
|
2015 |
Gonzalez BL, Gylys KH, Bilousova T. P1-004: Lipidation in cortical synapses of Alzheimer's disease versus normal controls Alzheimer's & Dementia. 11: P337-P337. DOI: 10.1016/J.Jalz.2015.06.200 |
0.321 |
|
2013 |
Tai LM, Bilousova T, Jungbauer L, Roeske SK, Youmans KL, Yu C, Poon WW, Cornwell LB, Miller CA, Vinters HV, Van Eldik LJ, Fardo DW, Estus S, Bu G, Gylys KH, et al. Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples. The Journal of Biological Chemistry. 288: 5914-26. PMID 23293020 DOI: 10.1074/Jbc.M112.442103 |
0.343 |
|
2012 |
Arold S, Sullivan P, Bilousova T, Teng E, Miller CA, Poon WW, Vinters HV, Cornwell LB, Saing T, Cole GM, Gylys KH. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex. Acta Neuropathologica. 123: 39-52. PMID 22020632 DOI: 10.1007/S00401-011-0892-1 |
0.382 |
|
2012 |
Sokolow S, Henkins KM, Bilousova T, Miller CA, Vinters HV, Poon W, Cole GM, Gylys KH. AD synapses contain abundant Aβ monomer and multiple soluble oligomers, including a 56-kDa assembly. Neurobiology of Aging. 33: 1545-55. PMID 21741125 DOI: 10.1016/J.Neurobiolaging.2011.05.011 |
0.361 |
|
2011 |
Joseph MS, Bilousova T, Zdunowski S, Wu ZP, Middleton B, Boudzinskaia M, Wong B, Ali N, Zhong H, Yong J, Washburn L, Escande-Beillard N, Dang H, Edgerton VR, Tillakaratne NJ, et al. Transgenic mice with enhanced neuronal major histocompatibility complex class I expression recover locomotor function better after spinal cord injury. Journal of Neuroscience Research. 89: 365-72. PMID 21259323 DOI: 10.1002/Jnr.22557 |
0.338 |
|
2009 |
Bilousova TV, Dansie L, Ngo M, Aye J, Charles JR, Ethell DW, Ethell IM. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. Journal of Medical Genetics. 46: 94-102. PMID 18835858 DOI: 10.1136/Jmg.2008.061796 |
0.474 |
|
2007 |
Carson MJ, Bilousova TV, Puntambekar SS, Melchior B, Doose JM, Ethell IM. A rose by any other name? The potential consequences of microglial heterogeneity during CNS health and disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 4: 571-9. PMID 17920538 DOI: 10.1016/J.Nurt.2007.07.002 |
0.552 |
|
2006 |
Bilousova TV, Rusakov DA, Ethell DW, Ethell IM. Matrix metalloproteinase-7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation. Journal of Neurochemistry. 97: 44-56. PMID 16515559 DOI: 10.1111/J.1471-4159.2006.03701.X |
0.565 |
|
2006 |
Spilman P, Campagna J, Jagodzinska B, Zhu C, Bai D, Hatami A, Bilousova T, Jun M, Alam MP, Elias CJ, Soler J, Bredesen DE, John V. O5-06-06: NORMALIZATION OF HIPPOCAMPAL SIRTUIN 1 LEVELS IN A MURINE APOLIPOPROTEIN E4-5XFAD MODEL OF AD RESTORES COGNITIVE FUNCTION Alzheimer's & Dementia. 14: P1659-P1660. DOI: 10.1016/J.Jalz.2018.06.3030 |
0.335 |
|
Show low-probability matches. |